Clinical Trials Directory

Trials / Unknown

UnknownNCT03436576

Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye

Comparison of Autologous Serum 20% and Autologous Serum 50% for the Treatment of Severe Dry Eye

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Pontificia Universidad Catolica de Chile · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effects of autologous serum 20% and autologous serum 50% for the treatment of Severe Dry Eye Syndrome

Detailed description

To determine the difference between autologous serum 20% vs 50%, in terms of improvement of symptoms, improvement of ocular surface parameters and acceptable tolerability in patients with severe dry eye syndrome.

Conditions

Interventions

TypeNameDescription
DRUGAutologous Serum 20%Instillation of 1 drop of Autologous Serum 20% four times a day
DRUGAutologous Serum 50%Instillation of 1 drop of Autologous Serum 50% four times a day

Timeline

Start date
2018-09-12
Primary completion
2018-10-19
Completion
2018-11-19
First posted
2018-02-19
Last updated
2018-09-05

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT03436576. Inclusion in this directory is not an endorsement.